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ABSTRACT

KEVIN C. O'LEARY
COGNITIVE BEHAVIORAL THERAPY WITH NON-AMBULATORY CLIENTS IN
THE TREATMENT OF DEPRESSIVE SYMPTOMS
2002 - 2003

DR. MARY LOUISE KERWIN
MASTER OF ARTS IN APPLIED PSYCHOLOGY AND MENTAL HEALTH
COUNSELING
The purpose of this study was to expand the current research on the effectiveness
of Cognitive Behavioral Therapy in the treatment of depressive symptoms with a nonambulatory client experiencing dysthymic depression. Using a single subject AB design,
Cognitive Behavioral Therapy was implemented during weekly sessions with Beck
Depression Inventory and the Leahy Anxiety Checklist for Patients as outcome measures.
Results suggest that Cognitive Behavioral Therapy can be used in the treatment of
depressive symptoms in non-ambulatory clients. Clients with physical disabilities who
experience mental illness have unique requirements suggesting the need for additional
research.

MINI-ABSTRACT

KEVIN C. O'LEARY
COGNITIVE BEHAVIORAL THERAPY WITH NON-AMBULATORY CLIENTS IN
THE TREATMENT OF DEPRESSIVE SYMPTOMS
2002 - 2003
DR. MARY LOUISE KERWIN
MASTER OF ARTS IN APPLIED PSYCHOLOGY AND MENTAL HEALTH
COUNSELING
In this study a non-ambulatory client was treated for symptoms of depression
using Cognitive Behavioral Therapy. Her progress was tracked through use of the Beck
Depression Inventory and the Leahy Anxiety Checklist for Patients. The study showed a
significant decrease in depressive symptoms as well as any symptoms of anxiety.
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Chapter 1
Introduction

Depression is a problem facing many Americans today. Depression is said to
affect between 6% and 25% percent of the population (American Psychiatric Association,
2000). Although many treatments are available for this difficult disorder, people are still
suffering everyday with its affects. The symptoms of depression are poor appetite or
overeating, insomnia or hypersomnia, low energy or fatigue, low self-esteem, poor
concentration or difficulty making decisions, and an overall feeling of hopelessness
(American Psychiatric Association, 2000). Depression can affect all facets of life
including job performance, marital relationships, social functioning and support. Severe
depression can result in feelings of hopelessness and suicide.
Many interventions have been developed to treat people with depression. These
treatments include psychoanalysis (Craighead, Evans, & Robins, 1992; Klerman, 1988;
Leichsenring, 2001;), Cognitive Behavioral Therapy (Rush, Beck, Kovacs, & Hollon,
1977; Kovacs et al., 1981; Hollon et al., 1989; Simons, Murphy, Levine, & Wetzel, 1985;
Hollon, DeRubeis, & Seligman, 1992), Mindfulness-Based Cognitive Therapy (Segal,
Williams, & Teasdale, 2001; Teasdale et al., 1995), Social Skills Training (Segrin, 2000;
Hersen, Bellack, Himmelhoch, & Thase, 1984; Lewinsohn & Gotlib, 1995), Behavioral
Activation Therapy (Jacobson, Martell, & Dimidjian, 2001), Electroconvulsive Therapy
(Klerman, 1988; Sackeim et al., 2000; Tremont & Stem, 2000) Psychopharmacological
Treatments (Depression Guideline Panel, 1993; Nemeroff& Schatzberg, 1998; Simon,
Von Korff, Rutter, & Peterson, 2001) and Problem Solving Therapy (Alexopoulos, Raue,
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& Arean, 2003; Katon et al., 2002; Frank et al., 2002; Townsend et al., 2001; Lerer &
Clum, 1990; Nezu & Perri, 1989).
Over the years, these techniques have been debated and tested with different
populations and different levels of depression. Although there are a variety of
approaches, the field has moved towards the use of empirically supported treatments.
Empirically supported treatments are defined as treatments that have been demonstrated
to have superior outcomes when compared to either control groups or "typically used
treatment approaches" they are evaluated within a randomized controlled experimental
study (Task Force on Promotion and Dissemination of Psychological Procedures, 1995).
The three techniques that appear in the literature as empirically supported
treatments of depression in adults are Cognitive Behavioral Therapy, Problem Solving
Therapy, and Medication Treatments (Hersen & Bellack, 1982; Oxman et al., 2001).
Cognitive Behavioral Therapy
The theory behind Cognitive Behavioral Therapy (CBT) is that a person's
symptoms or behaviors result from irrational beliefs or thoughts. If a person were to
reorganize their self-statements, they in turn would reorganize their behavior. There are
two main theorists of CBT who developed similar approaches at the same point in time
but relatively independent of each other.
Albert Ellis proposed Rational Emotive Behavior Therapy when he decided to
branch from the traditional psychoanalytic therapy and attempt to combine philosophical,
humanistic, and behavior therapy into one treatment (Ellis, 1962). Ellis believes that
mental health problems stem from irrational beliefs. Using a confrontational approach,
Ellis challenges these irrational distortions to demonstrate the control they have over the
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client's behavior. Once the client understands and accepts the impact of the distortions on
behavior, the client is encouraged to modify the beliefs.
At the same time, Aaron Beck was developing his own approach called Cognitive
Therapy (Beck, 1976). Beck's Cognitive Therapy allows the client to focus on his or her
cognition during a certain experience. Presenting the client with experiences that
challenge the underlying cognitive distortions enable the client to understand why he or
she feels a certain way and lead the client to change their core beliefs and therefore affect
the way they feel about a certain situation. One way these experiences are presented to
the client is through homework assignments to be accomplished outside of sessions
(Corey, 2001). Homework assignments have been shown to be a very important part of
CBT. In an experiment by David Coon, it was shown that homework compliance
contributed significantly to post treatment outcome as measured by both interviewadministered and patient self-report measures of depression (Coon & Thompson, 2003)
Both Ellis and Beck's therapies were very similar and at times they even
exchanged ideas. Rational Emotive Therapy and Cognitive Therapy have at their core
the assumption that faulty cognitions are the underlying problem and that changing these
faulty cognitions will result in changing affect and emotions.
Klosko and Sanderson (1999) describe CBT as a way for clinicians to intervene at
all the levels of depression. By teaching clients to manage their cognition, mood,
physiology, and behavior better, they can overcome their depression and meet their goals
in life. At the cognitive level, clients can correct their negatively distorted depressive
thoughts and think more realistically. At the level of mood, the client is taught selfcontrol techniques so they can better contain and manage the negative emotions. At the
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physiological level, the client is taught to use imagery, meditation, and relaxation
techniques such as activity scheduling and assertiveness training to help them behave in
more constructive ways. Overall, this technique builds on what is already healthy in the
client's life (Klosko & Sanderson, 1999).
Cognitive Behavioral Therapy is used as short-term therapy so the client can
manage their depression as quickly as possible and maintain these gains on their own.
Using CBT, the clinician must assume that the client is functioning at a reasonable level
so that they are able to attend all sessions, and have sufficient motivation to work with
the therapist to manage their depression.
In many studies researchers have seen improvements in depressive symptoms
using CBT. In adolescents diagnosed with Major Depression, Cognitive Behavioral
Therapy has been shown to be successful in decreasing the depressive symptoms (Gaynor
et al., 2003) even when set up as a standardized treatment (Ablon & Jones, 2002).
Cognitive Behavioral Therapy has been shown to be more effective than placebo in
experiments, but is shown to be even more effective when used in conjunction with
medication (Oei & Yeoh, 1999; Klerman et al., 1988).
In the experiment performed by Oei and Yeoh (1999), the population used was an
adult depressed population with no history of drug and alcohol abuse as well as no signs
of psychosis. In this study, CBT was compared to CBT with antidepressant medication.
The results showed that the medication did not take away from the treatment and both
groups showed dramatic improvement. The coauthor's concluded was that medication
should be used with extreme cases of depression where the client may not be able to
attend a CBT session.
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In research done by Taylor (2000), the treatment outcomes of clients diagnosed
with depression were equal when treated with Medication and with CBT. This researcher
used a severely depressed population and used the Beck Depression Inventory and
Hamilton Rating scale for Depression as outcome measures. This contradicts other
research showing that Cognitive Behavioral Therapy was the favored treatment in
treating depression (DeRubeis, Gelfand, Tang, & Simmons, 1999).
Although CBT has been demonstrated to be a superior treatment to placebo, the
methodology employed does expose limitations to these studies. When Cognitive
Therapy was compared to "other psychotherapies" in the treatment of depression, CT was
shown to be superior to the other therapies; however, the results may be due to the
experiment lumping "other therapies" into one category including both bona fide
treatments as well as treatment without therapeutic rational for depression (Wampold,
Minami, Baskin, & Tierney, 2002).
When CBT is compared to other treatments such as Psychodynamic-interpersonal
psychotherapy, CBT is shown to be more effective as a treatment in both the 8 and 16week trials using the Beck Depression Inventory as a measure. However, this
improvement was only seen in the more severe cases of depression (Shapiro, Barkham,
Rees, & Hardy, 1994).
Problem-Solving Therapy
Another common therapy that is used for depression is Problem-Solving Therapy
(D'Zurilla, 1986). Problem Solving therapy was developed in the early 1970's due to a
trend in psychology to develop an arsenal of more interventions for treatment of common
mental health problems (D'Zurilla, 1986). This treatment focuses on the client's

presenting issue within the framework of their current situation. The therapist takes this
presenting issue and develops an intervention designed for that client's particular
situation. So if a client comes in with an issue that is making them depressed or anxious,
the therapist would work on a direct intervention to correct that situation. For example, if
an adolescent is getting in trouble in school and feels that he cannot achieve in the
classroom, the clinician would design a specific plan for the adolescent such as staying in
his or her seat, listening, or finding someone in class that can help him or her stay out of
trouble. As a result, the treatment plan would be very concrete, specific, and behavioral.
This technique has been shown to work well with families and adolescents
(Haley, 1988). This treatment has also been used with the elderly and chronically ill
populations with some success (Katon et al., 2002). In an experiment with geriatric
patients, Problem-Solving Therapy has been shown to help reduce depressive symptoms
after 12 weeks of treatment (Alexopoulos et al., 2003). In a study comparing Paroxetine
and Problem-Solving Therapy with placebo for symptoms of depression as measured by
Hamilton Rating Scale, the combined therapy of medication and problem-solving was
superior to placebo (Katon et al., 2002). These treatments have also shown to have a low
rate of remission of depressive symptoms (Frank et al., 2002).
In a meta-analysis of the data, researchers have seen that people treated with
Problem-Solving Therapy show significantly greater improvement in scores for
depression, hopelessness, loneliness, and improvement over their problems than patients
who were in control groups (Townsend et al., 2001; Lemer & Clum, 1990; Nezu & Perri,
1989). The research has also shown that clients with emotional disorders treated with
Problem Solving therapy as compared to just general treatment from their family
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practitioner were seen to have fewer disability days and fewer days off work (MynorsWallis, Davies, Gray, & Barbour, 1997). The research also has shown that
psychopharmacology can help enhance results when working with some clients using
Problem-Solving Therapy (Resnikoff & Lapidus, 1998).
Medication Therapy
The next technique that is widely used in practice today is Medication Therapy.
There is increasing evidence that depression may result from physiological mechanisms.
This evidence comes from ongoing research, which has been studying the chemical
changes that occur in the body when someone is experiencing symptoms of depression.
Studies have found that when someone is going through depression, their levels of
norepinephrine and serotonin in their urine will decrease (Bunney, Murphy, & Goodwin,
1970). Later studies have confirmed that these two chemicals play a major role in a
person's mental state by studying the norepinephrine and serotonin levels in clients
experiencing manic symptoms. These researchers have found that when someone is
experiencing an episode of mania, their levels of norepinephrine are very high, but when
they are depressed, the levels are very low in their brain (Bunny et al., 1972). These
theories were again confirmed at a later date when researchers changed an individual's
serotonin and norepinephrine levels through changing their diets. These changes in
chemical levels affected the client's mood. When the client was taken off the special
diet, their mood and chemical levels returned to what it was before the experiment
(Delgado et al., 1990).
Medications help alleviate the symptoms of depression, especially eating,
sleeping and mood. Unfortunately, unlike CBT and Problem solving therapy that are
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intended to provide lifelong skills to combat depression and its symptoms, medications
are intended to alleviate the symptoms of the depression as long as medications are taken.
There are many different medications on the market that have shown to work well
for symptoms of depression. Some of the medications that have been demonstrated to
work best with depression are the antidepressants known as Tricyclic Antidepressants
(TCA's), Monoamine Oxidase Inhibitors (MAOI's) and Selective Serotonin Reuptake
Inhibitors (SSRI's) (Belanoff, DeBattista, & Schatzberg, 1998).
Tricyclic Antidepressants are a class of medication that exert their effects by
blocking the reuptake of excitatory neurotransmitters and secondary 5-HT and thereby
increase the amount ofneurotransmitter that is present in the synaptic cleft. These
medications are good because they are not affected by the intake of food. These
medications have some side effects but they usually subside over time. Although TCA's
are good for treating depression, they can be dangerous because an overdose on these
medications can be fatal (Buelow & Herbert, 1995; Bremner, 1984).
Monoamine Oxidase Inhibitors (MAOI) are used when clients are unresponsive to
other antidepressant medications. MAOI's work by inhibiting the enzyme that breaks
down the serotonin in the synaptic cleft. Therefore, by increasing the amount of
serotonin left in the synaptic cleft, the resulting increase of serotonin will help elevate the
client's mood. Unfortunately, MAOI's interact with many over the counter medications
as well as many foods. These medications are usually not tolerated by clients and are
rarely used as a first line defense against depression (Buelow & Herbert, 1995).
Selective Serotonin Reuptake Inhibitors (SSRI) work similarly to the TCA's by
blocking the reuptake of 5-HT neurotransmitter. SSRI medications tend to also help
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control obsessive rumination and have important anti-anxiety effects. SSRI medications
appear to work better than the TCA's since they have fewer side effects and are rarely
lethal in overdoses (Belanoff, DeBattista, & Schatzberg, 1998; Carrasco, Diaz-Marsa &
Saiz-Ruiz, 2000).
One medication that is commonly used in the treatment of depression is
Paroxetine, which is an SSRI. Paroxetine was developed in 1993 under the name Paxil.
This medication increases the amount of serotonin in the brain by inhibiting serotonin
reuptake. Fluoxetine (SSRI) is one of the most prescribed drugs for comorbid depression
and anxiety. It works on the 5-HT receptors by preventing the reuptake of serotonin in
the brain. Fluoxetine is also said to work on the 5-HT2 receptors. 5-HT2 is said to be
important in the regulation of mood. Sertraline (SSRI) tends to have the same effects as
fluoxetine by inhibiting the reuptake of serotonin. Unlike Fluoxetine, the effects of this
medication are delayed (Buelow & Herbert, 1995).
Combination of CBT and Medication
Clinical practice guidelines often suggest that the best results in treating
depression come from medication and therapy together (Koocher, Norcoss, & Hill, 1998;
Oei & Yeoh, 1999; Klerman, 1988). However, few studies have used methodologically
sound studies to empirically investigate the effectiveness of CBT and medication (Frank,
Kupfer, Perel, Comes, & Jarrett, 1990). Other research suggests that a combination of
CBT and medication is no more effective than CBT alone (DeRubeis et al., 1999; Jarret
et al., 1999). In the current study, a combination of medication (specifically Prozac) and
CBT will be used, consistent with the typical clinical practice guidelines for treatment of
depression.
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Treatment of Depression in Individuals with Physical Challenges
The empirically supported treatments reviewed thus far (CBT, Problem Solving
and Medication) are commonly used in isolation or combination to treat the symptoms of
depression. However, the majority of the literature has investigated their effectiveness
for depression in physically healthy adults. Unfortunately, not much research has been
done on people with physical disabilities and depression. Although the research suggests
that there is a higher rate of depression among people with physical limitations than in
the normal population (VanGundy & Schieman, 2001), I have not found any studies that
examine the effectiveness of interventions for depression with clients who are nonambulatory or disabled physically by accidents or birth defects.
The few published studies in this area involve the treatment of depression in the
elderly or people with physical illness (Van Gundy & Schieman 2001; Ban, Guy &
Wilson 1984; Bruce, 2001). The research that has been published suggests that treatment
of these individuals is not much different than the treatment of typical clients with
depression except that certain limitations have to be discussed and recognized (Rodin,
Craven, & Littlefield, 1991). Because the Cognitive Behavioral approach relies on
homework assignments involving physical tasks (i.e., going out to a crowded mall and
talking to a person for someone with social phobia), these therapeutic assignments have
to be considered more carefully by the therapist when working with individuals facing
physical challenges. If the client is not physically able to achieve the objective of the
assignment, the resulting client reaction may add more to the depression instead of
helping to reduce it through accomplishment. This will also add to the client's already
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negative schema that they may have saying that they are "worthless" or cannot achieve
anything on their own.
People who are physically challenged often receive multiple medications for their
physiological problems. These medications can have side effects that mimic depression
or anxiety (Ban, Guy & Wilson, 1984). A clinician treating someone in this population
needs to be aware of the medications the client is taking and be in constant contact with
the client's primary care physician in order to be updated on any medication increases or
changes that may occur. It is also necessary to recognize that a client with a physical
disability may not have issues with the physical side of their health or even the social
stigma. The client may be depressed over other life events such as family turmoil,
divorce, lack of socialization, or a death in the family (Rodin, Craven, & Littlefield,
1991; Bruce, 2001).
Overall, it appears that the best treatment of depression in general is to use a
combination of Cognitive Behavioral Therapy as well as Medication. The best
medication to use in stabilizing mood appears to be the Fluoxetine since it helps with
both depression as well as anxiety. These empirically supported and commonly used
treatment approaches for depression have not yet been investigated systematically in
individuals with physical limitation without physical illness. The purpose of this study is
to investigate the effectiveness of combined treatment of cognitive-behavioral therapy
and medication for the treatment of depression in an individual with physical limitations
using a single case design.
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Chapter 2
Method
Participant
Sally is a 21-year-old non-ambulatory client that sought help from a community
mental health agency for symptoms of depression and anxiety. Sally presents as an
intelligent and well-spoken 24-year-old white female with a slight stutter. She was born
with a birth defect that led to her being wheelchair bound and requiring extensive medical
treatment during her entire life. She comes from a middle class socioeconomic status and
is partially supported through disability and social security. She has lived at home with
her family, which consists of her mother, two sisters and one brother. She is the oldest
sibling in the family.
During her initial assessment she reported depression over her lack of family
involvement, social activities and friends. Sally reported that she has been generally
feeling "down" since she was 16 years old and her parents divorced. She reported
frequently losing her appetite, but still eating because she knew she had to take her
medications with food. Her sleeping patterns consisted of either sleeping too much some
days or not being able to sleep at all during others. She also appeared to have very low
self esteem and spoke about herself in a very negative fashion. She reported that the
majority of her day is spent by herself either reading or just staring out the window.
Sally reported feeling depressed about her current family situation. She felt that
she had no connection to her family after her parents' divorce. She also reported that the
family had separated into two fighting groups; the group that still had contact with her
father, and the group that wanted nothing to do with him.
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Sally also reported anxiety and depression when dealing with social situations.
She felt that no one would want to talk to her and she was embarrassed to start
conversations with people because of her stutter. While exploring the origin of these
feelings, Sally reported that when her parents were divorcing, she had one friend she felt
she could talk to about everything in her life. When things started to get messy with the
divorce, Sally perceived that her friend rejected her. This caused Sally to hold in most of
her feelings and blame herself for most of her difficulties in life.
Sally's feelings of anxiety and depression were impacted by many stressors
including lack of reliable transportation, lack of physical adaptations in her home, her
mother's tendency to leave her in charge of the care of the siblings, the family's schedule,
and a house without adequate physical support.
Sally had previously been in treatment for the same issues during the previous
year. Those sessions were terminated early when the therapist had to leave the agency.
Before Sally sought therapy, she started receiving Prozac from her family physician to
help combat her depression. Once Sally had started treatment at this facility, the
agency's psychiatrist took over her medication monitoring. Prozac is the only medication
Sally was taking at the start of this study.
Measures
The measures used in this study were the Beck Depression Inventory and the
Leahy Anxiety Checklist for Patients.
Beck Depression Inventory. The Beck Depression Inventory (BDI) is a 21 item
self-report questionnaire assessing symptoms of depression. The questions break down
depression into different areas such as physical symptoms, feelings, and cognition. These
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items are rated on a scale from 0 to 3, with three being the most severe and zero meaning
that the symptom does not exist. The scores are then added up and the total indicates the
severity of the depression or the absence of depression. A score of 5-9 indicates a typical
experience, 10-18 indicates mild to moderate depression, 19-29 indicates a moderate to
severe level of depression and anything over 30 indicates a severe level of depression.
The coefficients alpha estimates of reliability for the BDI with an outpatient population
of adults was .92 and the test-retest reliability coefficient across the period of a week was
.93. The BDI and the Hamilton Psychiatric Rating Scale for Depression - Revised are
correlated .71 providing some support for the validity of the BDI as a.measure of
depression.
Leahy Anxiety Checklist for Patients (LACP). The Leahy Anxiety Checklist for
Patients is another self-report questionnaire that measures symptoms of anxiety as well as
the severity of anxiety as reported by a client. This is a 17-question assessment that uses
a rating number scale of 1-4; 1 being the lowest (Not at all) to 4 being the highest (Very
true). This scale examines physical symptoms as well as the inner worries and fears.
Scores between 5 and 10 reflect mild anxiety, 11 - 15 moderate anxiety, and 16 or higher
significant anxiety (Leahy & Holland, 2000).
The LACP is intended to be used in conjunction with other measurements as a
way to detect changes in anxiety over time. The LACP was taken from a treatment
Planner called "Treatment Plans and Interventions for Depression and Anxiety
Disorders" (Leahy & Holland, 2000). The instrument was not tested for reliability or
validity but was instead used as a way to compare the anxiety levels from session to
session.
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Design
The design of the study was a single subject AB design where A was the baseline
and B was Cognitive Behavioral Treatment. A baseline was taken during the first session
for Depression and the baseline for the anxiety was determined at the 8th session of
treatment. Both anxiety and depression were monitored through the administration of the
two assessments. The measures were given to the client in the waiting room before the
treatment to assess her general mood during the week.
Procedure
Informed consent. When Sally first entered into treatment at the agency, she was
informed of her rights as a client. She was also given all the limits of confidentiality and
was told that I was a student intern at the agency. She was given the name and number of
my supervisor as well as my thesis sponsor. She was informed that her identity would be
disguised and her participation in the study would have no affect on her treatment and she
was allowed to withdraw her participation at anytime. At this time Sally provided
informed consent for the study.
Baseline. When Sally first entered treatment, her initial complaint was
depression. She described herself as being very depressed and we used that as our first
treatment goal. At the end of the first session, I described to Sally the type of treatment
we would be doing and how we would have to measure our progress. The first BDI was
administered in the office on that day and Sally was told that she would be filling these
out every other week in the waiting room so we could track our progress and use it to see
what was working and what was not working. After that initial assessment, the measure
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was left on a clipboard in the waiting room for Sally so she could begin working on it as
soon as she came into the agency.
Midway through the treatment, Sally began experiencing symptoms of high
anxiety. It was at this time that the Leahy Anxiety Checklist for Patients was introduced.
Once again it was explained to Sally that we would use this instrument to measure her
level of anxiety from session to session. The Leahy was administered every other week
and was left on a clipboard in the waiting room. The Beck and the Leahy measurements
were not given on the same week, and were instead alternated so Sally would not have to
spend too much time in each session filling out assessments.
Both of these measurements were graphed and presented before each session as a
way to see what was working and what was not working.
Treatment. In this study, Cognitive Behavioral Treatment was used to address
Sally's symptoms of depression and later on to help lower Sally's feelings of anxiety.
The first part of the treatment explored some of Sally's negative schema and cognition.
This was the cognitive part of the treatment that was done primarily in the office. We
discussed much of what was occurring in Sally's life as well as how she saw herself in
each situation. Some of the techniques used were role-playing, challenge, and empty
chair. These techniques were used as a way for Sally to practice how she would handle a
negative situation, as well as a way for her to see how her actions and negative schema
affected her mood. These techniques were also used by myself to model better coping
mechanisms as well as a way to show Sally's how she was acting and how others could
perceive what she was doing. All of this was done in the office and we were able to stop
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periodically to show how her negative cognition was directing her behavior and mood.
All together we met for 15 sessions and sessions lasted 50 minutes a piece.
The behavioral side of the treatment came when Sally was expected to act out
situations in the office that caused her to feel bad and then play out a possible scenario
where she would leave not feel as bad. By allowing Sally to experience both sides of a
conversation or scenario, she was able to see how one might feel about her and how she
could perceive herself in a positive light. This was a way for her to demonstrate and
begin using her now positive schema that the cognitive side of our treatment allowed her
to build.
The behavioral side of the treatment began outside of the office after Sally began
to feel more comfortable and was ready to begin asserting her new skills. This part of the
therapy was given as homework assignments. These homework assignments were small
tasks designed to get Sally asserting herself and to test other's reactions to her behavior.
By allowing her to be assertive in small doses and being successful in making small
changes in her life, she was challenging her negative schema that was the root of her
depression. These challenges did not always work out the first time, and when they did
not, we would revert back to the office for more role-playing and cognitive examination
of what occurred. Once Sally was more confident in her new skill and approach, she was
given the same homework assignment over again until she was successful in making the
change that she had wanted. Once these small changes were complete, Sally was ready
to confront some of the larger issues in her life. These homework assignments were
given periodically during the 15 sessions and Sally was able to successfully complete
about 50% of the assignments given on the first try. When given another try at the same
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homework assignment, Sally was almost always.able to complete it. The few
assignments she was not able to complete, she was at least able to make an attempt and
be able to explain why she was not successful. These failures proved to be helpful to
Sally since she saw herself able to see herself trying and not getting overly depressed
when failing.
During Sally's 5th session, she reported signs of anxiety and described herself as
suffering from symptoms of panic attacks. These panic attacks, as well as being scary to
Sally, elevated her levels of depression. To better deal with the panic and anxiety, deep
breathing and relaxation exercises were introduced. Because Sally's mobility was limited
due to her disability, we concentrated more on deep breathing, progressive muscle
relaxation, and meditation. At this same time Sally's psychiatrist was consulted to check
her Prozac levels and decrease her prescription to help combat the anxious thoughts and
feelings. Over the next few sessions we worked together on the anxiety as well as
continued to monitor and deal with the depression. Sally's medication was lowered after
the 10th session and this appeared to make a major difference in her reported symptoms
of anxiety.
The cognitive component of this treatment was educating Sally on possible causes
of her anxiety and letting her know that the anxiety, although scary, would not result in
permanent harm. Sally learned ways to reduce the level of her anxiety. The behavioral
side of the treatment came with practicing the various deep-breathing techniques in the
office until Sally felt confident enough to do them on her own at home.
Over the last few sessions, Sally had completed all the challenges that were
assigned as well as becoming comfortable with her relaxation exercises. At this point we
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set up a termination date for her treatment and decided on one last follow-up session
scheduled three weeks after the last session to check up on her progress.
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Chapter 3
Results

Baseline for Depression
On the first administration of the Beck Depression Inventory (BDI) Sally scored
26 placing her in the "moderate to severe depression" range. Figure 1 depicts the data on
depression.
Treatment on Depression
After the first month of treatment, Sally's score changed from an average of 26
(moderate to severe depression) to an average of 16 (mild to moderate depression) on the
BDI. This was a dramatic decrease for only a month of treatment. Her score stayed at
this level for the next two sessions. At session 6, her score once again dropped
dramatically and stayed around the area of 1 to 4 (considered normal).
During the session eight, there is a slight increase in Sally's level of depression.
This was attributed to Sally's report of "anxiety attacks" as well as a change in her
transportation service. Sally had also had an increase in her medication and all these
factors appeared to be causing a significant amount of anxiety. It was at this point that
we began using the Leahy Anxiety Checklist for Patients.
Baseline for Anxiety
The first baseline measure was administered in the office during session 8 (see
Figure 2). The initial baseline score was 37, which was in the severe range for anxiety.
This was a very high score for someone who was still functional. When we talked about
the checklist, Sally explained that the panic attacks had been overwhelming and she felt it
was necessary to score herself high on all levels of the anxiety checklist.
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Treatment on Anxiety
Sally's anxiety level started out at 37 and quickly dropped to 23, then finally to
around 2 near the end of treatment. This drop occurred over a period of 4 months and at
no time did the score rebound during the process (see Figure 2).
Both the anxiety and depression levels dropped dramatically during treatment and
aside from the small increase in the BDI score at around the 8 h session when Sally began
experiencing her anxiety, there was little to no fluctuation in scores.
Sally's follow up appointment occurred 3 weeks after our last appointment. She
completed both the BDI and the LACP. She scored a 0 on the BDI and a 3 on the LACP
while verbally reporting that she felt no signs of anxiety or depression since our last
appointment.

21

Chapter 4
Discussion

A non-ambulatory client was treated for 22 weeks with a combination of
Cognitive Behavioral Therapy and Medication. Over that 22-week span of treatment, the
client was able to successfully overcome her depression and anxiety symptoms and began
to see a higher rate of functioning overall.
The Cognitive Behavioral Therapy techniques that were used were role-playing,
challenge, empty chair, and modeling. Through practice in the office, examination of
schema, and challenge in the form of homework assignments, Sally was slowly able to
decrease her level of depression.
Midway though treatment, Sally began to experience symptoms of anxiety. We
were able to decrease the symptoms of anxiety through progressive muscle relaxation,
positive visualization, deep breathing, meditation, and a change in her current
medication. Through the use of these techniques, Sally's score on the Beck Depression
Inventory as well as her score on the Leahy Anxiety Checklist for Patients dramatically
decreased back to a normal range of functioning.
There were some changes made to the treatments used due to the client's physical
handicap. When discussing any changes that would have to be made in Sally's overall
daily tasks, other factors had to be taken into consideration. An example of this
adjustment was when Sally discussed wanting to become financially independent. Sally
had to take into account her disability insurance, as well as her Social security since she
would lose both once she began working full time. If Sally would discuss wanting to go
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off to do something on her own, her limitations and personal care had to be taken into
account since she was restricted due to cathitarization as well as wheelchair mobility.
Any small changes that were going to be made had to be made in the context of her
physical limitations. These limitations also had to be taken into account when thinking
up challenges for Sally to test her skills. If the challenge was not appropriate for her
condition, the eminent failure that would have resulted would have fed into her negative
schema, and therefor resulted in an increase in her depression.
During the treatment, there was a sudden rise in anxiety symptoms. Sally had
experienced some anxiety in her past; she identified her current state as one of panic.
This sudden rise in anxiety symptoms could have been the result of an increase in her
Prozac or a change in the current family situation. At the time of the anxiety, Sally was
currently making some changes in her role in the family. She was declaring more
independence and although she stated that her new sense of independence felt good, it
also worried her since it was a new feeling. This sudden change from depression to
anxiety could have been a direct result of the treatment, but Sally was able to work
quickly to combat these symptoms through a decrease in her medication as well as
numerous relaxation techniques.
This study can be readily applied to almost any person with a physical disability
that allows them to function in society with minor aide. If a person comes to treatment
with signs of depression and is completely paralyzed, the use of CBT may not be
appropriate and the treating therapist should seek other forms of treatment that would be
more appropriate.
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When doing Cognitive Behavioral Therapy, the ideal treatment rate would have
been to see the client about three times a week. This was not possible in our agency due
to appointment availability as well as transportation for the client. I would have also felt
it to be beneficial to have had some sessions out of the office where Sally would be able
to take me through her physically limited situations and then suggest direct changes. I
feel that by using this very direct technique, Sally would have been able to see immediate
results and therefore improve faster. I would have also liked to use more measurements
in the study. Due to a limited time frame before and after our sessions, we had to limit the
number of measurements we used.
One of the major obstacles that we encountered was the transportation to and
from the sessions. Since Sally had to rely on county assisted transportation that was not
very reliable; we missed many sessions in the beginning of treatment. Another limitation
to the treatment was my schedule. Since I was only at the agency two nights a week, it
did not allow for flexibility in our appointments. So if Sally was not able to make her
appointment at a certain time, it was very difficult to reschedule for another time before
the next week.
During the treatment, the client also experienced a major shift in her role in the
family when her sister left the household. When this change occurred, we were able to
work it into the treatment as a challenge and worked on ways to make this shift in family
dynamics work in her favor. There is no way of telling how this change in family would
have affected Sally if she were not in the current treatment. Since this was not a
controlled situation, these minor changes over time could have affected the data instead
of just the Cognitive Behavioral Therapy.
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There were several limitations of this study. First, the design utilized was a quasiexperimental design. Therefore, it does not control for confounding variables that might
have lead to changes in reported symptoms of depression and anxiety. Some of the
obvious confounds in this study were: statistical regression to the mean, changes in
medication during the study, family events, and repeated measurement. There was no
way to tell if it was the Cognitive Behavioral Therapy that was the sole factor in the
alleviation of depressive symptoms.
If this experiment were to be conducted again, I would have made a few changes.
The first change I would have made would have been to use numerous measurements in
the treatment. This would require clients to arrive early for the appointments and fill out
measurements each week. I would have also liked to have the flexibility to have more
sessions in the beginning of treatment as well as reliable transportation for the clients so
there would be no chance of missed appointments.
I believe it would have been good to be able to see many different clients with
different disabilities to see what the effect would have been on clients who were not only
non-ambulatory, but were maybe missing other appendages, as well as clients from
different backgrounds both cultural and socioeconomic. I believe that future research
should focus in on these other groups within the handicapped population in order to really
gain a full understanding on how Cognitive Behavioral Therapy will work with clients of
different abilities.
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